Dogecoin and Dogwifhat dominate meme coin news, but Smart Yield Coin’s presale has raised $100K with real-world features, tipped for 50x gains by analysts.Dogecoin and Dogwifhat dominate meme coin news, but Smart Yield Coin’s presale has raised $100K with real-world features, tipped for 50x gains by analysts.

DOGE Meets WIF in Meme Spotlight, But Smart Yield Coin Captures Early Investors

dogecoin-15 main image 4 17

In the latest Dogecoin news, DOGE has been back in the news with renewed activity, once again drawing attention to the meme coin space. Dogwifhat (WIF), Solana’s viral pink-hat token, has also stayed in focus as traders bet on its next move. But outside the memes, a new crypto is carving its own path, already raising nearly $100,000 from early investors who see value in its income-driven model.

Smart Yield Coin presale captures early investor confidence

Smart Yield Coin (SYC) is quickly proving that it is more than just another presale project. While meme tokens like DOGE and WIF thrive mainly on community energy, SYC is carving out a practical path by positioning itself as a decentralized alternative to traditional banking. The project offers investors a secure way to save, build, and spend their crypto holdings without the uncertainty that typically accompanies presale coins.

What sets SYC apart is its range of real-world features designed to tackle everyday challenges. Its AI Gas Prediction tool helps users reduce transaction fees by pinpointing more cost-effective network times. Staking without lockups allows holders to earn rewards flexibly, while AutoMine turns ordinary internet bandwidth into passive income. To top it off, SmartYield Pay connects crypto to daily life, enabling spending across 900 currencies through debit cards.

Unlike speculative offerings, Smart Yield Coin has emphasized credibility through audits, legal incorporation, and partnerships with established technology providers. This foundation, combined with sustainable tokenomics, has already drawn nearly $100,000 in presale funding at $0.015, showing strong investor confidence in its long-term value.

Dogecoin news puts meme coin back in the spotlight

The Dogecoin news of the day has once again put the meme coin at the forefront, as its performance remains consistent at $0.215 with a 1.33% on the daily chart. Dogecoin has also established a reputation for being resilient, demonstrating that community strength and momentum can keep it relevant in the competitive marketplace. 

image 4 16

Source: TradingView

In the meantime, one new project is in the news: Dogecoin is institutionalizing, via a $200 million Digital Asset Treasury, chaired by Alex Spiro, Elon Musk’s lawyer. This move could foster stronger institutional confidence, taking Dogecoin beyond retail-driven hype. 

If the treasury rollout is successful, Dogecoin may move toward the $0.25–$0.30 range, further solidifying its position as the top meme coin of 2025.

Dogwifhat price holds $0.80 support as buyers eye a push toward $1

Dogwifhat (WIF) is trading at $0.806, showing a modest daily gain of +2.94% after bouncing from a recent low of $0.756. Despite the short-term uptick, Dogwifhat remains under pressure, with a 1-month ROI of 12.40% and a 1-year ROI of 47.90%, reflecting a prolonged bearish phase.

image 4 16

Source: TradingView

The WIF price chart shows strong resistance around $1.32, where earlier rallies were rejected, while support is consolidating near $0.75. Current movements indicate cautious accumulation, with buyers defending key levels, but momentum remains weak compared to the highs seen earlier in the year.

If Dogwifhat can sustain above $0.80 and attract stronger volume, it could retest the $0.95–$1.00 zone. However, failure to hold support may drag it toward $0.70 in the short term.

Smart Yield Coin tipped for 50x gains over DOGE and WIF

Smart Yield Coin is emerging as the serious play in a market crowded with meme-driven speculation. While Dogecoin and Dogwifhat remain popular for their communities and cultural pull, SYC’s utility, transparency, and strong presale traction position it differently. With nearly $100,000 already raised and innovative features that solve real problems, analysts see it as a project with the potential to deliver 50x gains and outperform both DOGE and WIF.

Take advantage of the Smart Yield Coin (SYC) presale right now: Website | Telegram | Twitter/X

Market Opportunity
RealLink Logo
RealLink Price(REAL)
$0.07916
$0.07916$0.07916
-1.72%
USD
RealLink (REAL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26